About GA

Impact on Patients

Visual Acuity ≠ Visual Function

Monitoring for progression can be difficult since disease progression is NOT always correlated with a decline in visual acuity, particularly with extrafoveal lesions.

To get a complete look at how geographic atrophy (GA) is impacting your patients, you can go beyond best corrected visual function (BCVA) by evaluating functional assessments.3,4

Functional Tests to Assess GA

May be used to detect abnormal visual function in patients with good BCVA4

Deficits in LLVA are associated with higher GA lesion progression rates3

Delayed dark adaptation may provide evidence of age-related macular degeneration (AMD) before the appearance of clinical features, such as drusen and focal pigmentary changes12

A decrease in retinal sensitivity can correlate with lesion enlargement over time3,25

GA Changes Lives

Geographic atrophy (GA) can have an impact on patients’ emotional well-being, leading to feelings of anger, frustration, isolation, fear, and depression.18,20,26 Emerging therapies may offer eye care professionals the opportunity to slow the progression of GA and help patients address some of the biggest obstacles they face in their day-to-day lives.21

Patients Lose More Than Just Vision
63% of patients with geographic atrophy reported difficulty reading

Reported difficulty reading for everyday tasks or leisure20

88% of patients with geographic atrophy lose confidence driving at night

Lose confidence driving at night19

67% of patients with geographic atrophy lose their ability to drive in 1.6 years after diagnosis

Will lose their ability to drive in
1.6 years after diagnosis16

Treatment Considerations

Treatment options exist for patients with GA secondary to AMD. Explore the clinical data about an FDA approved treatment option for your patients.

Learn more here